Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder
This study concluded that Gazelle provides, for the first time, an affordable and rapid solution for identifying beta-thal at point of care.
- This study concluded that Gazelle provides, for the first time, an affordable and rapid solution for identifying beta-thal at point of care.
- The ability to test accurately and rapidly (results are available in 8 minutes) as demonstrated in this study suggests that Gazelle is suitable for large-scale testing of beta-thal at point of care.
- Beta thalassemia is an inherited blood disorder.
- A study published in the European Journal of Hematology has shown, however, that incidence rates decrease in areas with screening and education programs.